Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1457 publications

Blood-Based Cell-Free DNA in Ophthalmic Oncology.

Blood-Based Cell-Free DNA in Ophthalmic Oncology.

Journal: Translational vision science & technology
Published: October 06, 2025

Correction: Shoushtari et al. A Phase Ib Study of Sotrastaurin, a PKC Inhibitor, and Alpelisib, a PI3Kα Inhibitor, in Patients with Metastatic Uveal Melanoma. Cancers 2021, 13, 5504.

Correction: Shoushtari et al. A Phase Ib Study of Sotrastaurin, a PKC Inhibitor, and Alpelisib, a PI3Kα Inhibitor, in Patients with Metastatic Uveal Melanoma. Cancers 2021, 13, 5504.

Journal: Cancers
Published: August 08, 2025

Choroidal Metastasis Presenting As Anterior and Posterior Scleritis: A Rare Manifestation of a Previously Unknown Metastatic Cutaneous Melanoma.

Choroidal Metastasis Presenting As Anterior and Posterior Scleritis: A Rare Manifestation of a Previously Unknown Metastatic Cutaneous Melanoma.

Journal: Cureus
Published: August 07, 2025

Response to Letter to the Editor Regarding: An Open-Label, Randomized Study of Melphalan/Hepatic Delivery System Versus Best Alternative Care in Patients with Unresectable Metastatic Uveal Melanoma.

Response to Letter to the Editor Regarding: An Open-Label, Randomized Study of Melphalan/Hepatic Delivery System Versus Best Alternative Care in Patients with Unresectable Metastatic Uveal Melanoma.

Journal: Annals of surgical oncology
Published: July 29, 2025

Fundus Depigmentation after Immunotherapy for Metastatic Uveal Melanoma.

Fundus Depigmentation after Immunotherapy for Metastatic Uveal Melanoma.

Journal: Ophthalmology. Retina
Published: July 19, 2025

ASO Visual Abstract: An Open-Label, Randomized Study of Melphalan/Hepatic Delivery System versus Best Alternative Care in Patients with Unresectable Metastatic Uveal Melanoma.

ASO Visual Abstract: An Open-Label, Randomized Study of Melphalan/Hepatic Delivery System versus Best Alternative Care in Patients with Unresectable Metastatic Uveal Melanoma.

Journal: Annals of surgical oncology
Published: July 15, 2025

GDF15 reprograms the microenvironment to drive the development of uveal melanoma liver metastases.

GDF15 reprograms the microenvironment to drive the development of uveal melanoma liver metastases.

Journal: bioRxiv : the preprint server for biology
Published: July 14, 2025

Surgical management of pulmonary metastases secondary to uveal melanoma: a case series.

Surgical management of pulmonary metastases secondary to uveal melanoma: a case series.

Journal: Melanoma research
Published: July 14, 2025

An Open-Label, Randomized Study of Melphalan/Hepatic Delivery System Versus Best Alternative Care in Patients with Unresectable Metastatic Uveal Melanoma.

An Open-Label, Randomized Study of Melphalan/Hepatic Delivery System Versus Best Alternative Care in Patients with Unresectable Metastatic Uveal Melanoma.

Journal: Annals of surgical oncology
Published: July 08, 2025

Single-cell profiling deciphering cholesterol metabolism dysregulation in metastatic uveal melanoma and implicating SLC45A2 in its prognosis.

Single-cell profiling deciphering cholesterol metabolism dysregulation in metastatic uveal melanoma and implicating SLC45A2 in its prognosis.

Journal: Frontiers in immunology
Published: July 05, 2025

Artificial intelligence-assisted assessment of metabolic response to tebentafusp in metastatic uveal melanoma: a long axial field-of-view [18F]FDG PET/CT study.

Artificial intelligence-assisted assessment of metabolic response to tebentafusp in metastatic uveal melanoma: a long axial field-of-view [18F]FDG PET/CT study.

Journal: European journal of nuclear medicine and molecular imaging
Published: July 02, 2025

Unexpectedly Low Rate of Metastasis and Death Among Patients Treated for Uveal Melanoma with Brachytherapy, Vitrectomy, and Silicone Oil.

Unexpectedly Low Rate of Metastasis and Death Among Patients Treated for Uveal Melanoma with Brachytherapy, Vitrectomy, and Silicone Oil.

Journal: Cancers
Published: June 28, 2025
Showing 1-12 of 1,457

Last Updated: 10/31/2025